Furukawa and colleagues have obtained images showing for the first time how different domains of the NMDA receptor move when the receptor is in active, non-active, and inhibited states. Understanding how NMDA receptors activate is critical in designing novel therapeutic compounds for potential use in schizophrenia, depression and other disorders. Credit: Furukawa Lab, CSHL
Researchers have obtained images of the NMDA receptor in active, non-active, and inhibited states. Understanding how NMDA receptors activate is critical in designing novel therapeutic compounds for schizophrenia, depression, Alzheimer’s and other illnesses...
Read More
Recent Comments